Predictors of outcome in patients with suspected myocarditis

Circulation

Volumn 118, Issue 6, 2008, Pages 639-648

  Kindermann, Ingrid ^a   Kindermann, Michael ^a   Kandolf, Reinhard ^c   Klingel, Karin ^c   Bültmann, Burkhard ^d   Müller, Thomas ^a   Lindinger, Angelika ^b   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Klinik für Allgemeine Pädiatrie und Neonatologie   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Abteilung Allgemeine Pathologie   (Germany)

Author keywords

Biopsy; Cardiomyopathy; Immunohistochemistry; Molecular biology; Myocarditis

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GENE IDENTIFICATION; HAZARD RATIO; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TIME SERIES ANALYSIS; UNIVARIATE ANALYSIS; VIRUS GENOME; VIRUS MYOCARDITIS; BIOPSY; CONGESTIVE CARDIOMYOPATHY; HEART STROKE VOLUME; HEART VENTRICLE PRESSURE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDITIS; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION;

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ALDOSTERONE ANTAGONISTS; BIOPSY; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; GENOME, VIRAL; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR PRESSURE; VIRUS DISEASES;

EID: 50349094756     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.769489     Document Type: Article

References (34)

1. Feldman AM, Mc Namara D. Myocarditis. N Engl J Med. 2000;343: 1388-1398.
2. Kawai C. From myocarditis to cardiomyopathy: mechanism of inflammation and cell death: learning from the past for the future. Circulation. 1999;99:1091-1100.
3. Pauschinger M, Noutsias M, Lassner D, Schultheiss HP, Kuehl U. Inflammation, ECG-changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol. 2006;95:1-15.
4. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R, for the American Heart Association, American College of Cardiology, and European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-2233.
5. Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res. 2003;60:5-10.
6. D'Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvrestri F, Di Sciascio G. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001;85:499-504.
7. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, for the American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816.
8. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876-890.
9. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000; 342:690-695.
10. Grogan M, Redfiel MM, Bailey KR, Reeders GS, Gersh BJ, Edwards WD, Roedeheffer RJ. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. JAm Coll Cardiol. 1995;26:80-84.
11. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109:1250-1258.
12. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bueltmann B, Kandolf R. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol. 1996;70:8888-8895.
13. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
14. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841-842.
15. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114:1581-1590.
16. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104:39-45.
17. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol. 2004;193:101-117.
18. Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell CR, Heiner C, Kent SB, Hood LE. Fluorescence detection in automated DNA sequence analysis. Nature. 1986;321:674-679.
19. Murray DR, Prabhu SD, Chandrasekar B. Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 2000;101:2338-2341.
20. Wang JF, Meissner A, Malek S, Chen Y, Ke Q, Zhang J, Chu V, Hampton TG, Crumpacker CS, Abelmann WH, Amende I, Morgan JP. Propanolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am J Physiol Heart Circ Physiol. 2005;289: H1577-H1583.
21. 2-adrenergic receptors on cardiac myocytes apoptosis: role of a pertussin toxin-sensitive G-protein. Circulation. 1999;100: 2210-2212.
22. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
23. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
24. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation. 1996;94: 2930-2937.
25. Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival in mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003;41:340-345.
26. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593-595.
27. Deckers JW, Hare JM, Baugham KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19:43-47.
28. Pophal SG, Sigfusson G, Booth KL, Bacanu SA, Webber SA, Ettedgui JA, Neches WH, Park SC. Complication of endomyocardial biopsy in children. J Am Coll Cardiol. 1999;34:2105-2110.
29. Hauck AJ, Kearney DL, Edwards W. Evaluation of post-mortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clinic Proc. 1989;63:1235-1245.
30. Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. JAm Coll Cardiol. 1989;14:915-920.
31. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;31:885-890.
32. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084.
33. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis: the Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:269-275.
34. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793-2798.